Cardiome plunges as drug indexes climb

Cardiome Pharma shares plunge in early trading on news that a key clinical trial for its cardiac drug had been halted over safety concerns.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.